| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-09 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.32 | 8e-07 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 9e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |